Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron to reduce ephedrine ED50 for preventing post-induction hypotension in elderly general anesthesia patients
ChiCTR2000040344Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of granisetron and ephedrine in hypotension (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Noninvasive blood pressure. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
granisetronephedrine
03
Conditions
hypotension
Beyond the preview
Go deeper on ChiCTR2000040344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040344.